T Cell Kit for mRNA
Rethink Cell Therapy with Lipid Nanoparticles.
The GenVoy-ILM T Cell Kit for mRNA is an LNP reagent mix optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges. It can be used at various stages of cell therapy research and development from discovery to preclinical.
GREATER PROPORTION OF ENGINEERED CELLS
HIGH CELL VIABILITY
Nucleic acids delivered using the GenVoy-ILM T Cell Kit for mRNA are potent without causing cytotoxicity, resulting in highly viable cells that can be assayed in vitro and in vivo.
UNIFORM CELLULAR PROTEIN EXPRESSION
Delivering mRNA into activated human primary T cells using the GenVoy-ILM T Cell Kit for mRNA leads to a higher proportion of engineered T cells, making it a more potent gene delivery method than electroporation.
Engineering T cells using the GenVoy-ILM T Cell Kit for mRNA results in uniform protein expression across the treated cell population.
High Cell Viability
Activated human primary T cells remain highly viable after ex vivo gene delivery using the GenVoy-ILM T Cell Kit for mRNA.
Easily Integrated into Standard T Cell Culture Protocols
GenVoy-ILM T Cell Kit for mRNA
vs Electroporation Protocol